Home / Benchmarks / Healthtech
HealthtechM&A Activity
Deal flow, active acquirers, and current market trend - based on 32real disclosed M&A transactions in the healthtech space. Run the calculator below to price your business at current multiples.
State of HealthtechM&A in 2026
The healthtech M&A market is tracked across 32 disclosed transactions in the ExitValue.ai database (25 with EBITDA disclosed, 32 with revenue). The current market trend is growing.
Active acquirers include Transcarent, Inc., RadNet, Inc., MDaudit, Vista Equity Partners. Recent named transactions: Accolade, Inc. (2025); iCAD, Inc. (2025); Streamline Health (2025).
Premium valuations in healthtech are driven by recurring saas revenue; regulatory clearance pipeline; clinical validation.
What compresses valuations: regulatory approval risk; reimbursement uncertainty; long sales cycles.
Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.
Recent named M&A deals in healthtech
Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).
Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.
Get an instant valuation for your healthtech
Backed by the same 32 disclosed transactions, adjusted for your specific size and margin.
Get your full valuation analysis
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
What drives a premium valuation
- ●recurring SaaS revenue
- ●regulatory clearance pipeline
- ●clinical validation
- ●health system adoption
- ●data assets
What compresses valuation
- ●regulatory approval risk
- ●reimbursement uncertainty
- ●long sales cycles
- ●clinical evidence requirements
- ●competition from EHR vendors
Healthtech valuation: common questions
How is a healthtech business valued?
Healthtech businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.
What drives healthtech valuation?
The biggest value levers in healthtech are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for recurring saas revenue; regulatory clearance pipeline; clinical validation.
How many healthtech M&A deals are tracked?
ExitValue.ai tracks 32 disclosed healthtech M&A transactions, 25 with EBITDA disclosed, 32 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: growing.
Who buys healthtech businesses?
Healthtech businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Transcarent, Inc., RadNet, Inc., MDaudit, Vista Equity Partners.
What is my healthtech business worth?
Run the ExitValue.ai healthtech calculator to see your business priced against the 32 disclosed healthtech transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.
More on healthtech valuations
- Healthtech valuation calculator· head-term variant
- Who buys healthtech businesses?· active buyers
- Recent deal: Accolade, Inc.· comparable transaction
- Who acquired Accolade, Inc.?· buyer profile
Methodology details: how ExitValue computes valuation ranges · full healthtech calculator